Total knee replacement in patients with hemophilia with severe axial deformation and combined instability
https://doi.org/10.29235/1814-6023-2020-17-2-191-202
Abstract
We have analyzed results of treatment of 23 (30 knee joints) patients, including Hemophilia A – 22 cases (73.3 %) and Hemophilia B – 8 (26.7 %), with III–IV stages of hemophilic arthropathy, who were operated on for severe combined instability and various types of deformations: varus – 8, valgus – 11, recurvation – 2, “сompensated” valgus-varus – 3; totally 30 TKRs. In 7 patients (30.4 %) both knee joints were operated on. TKR of the right knee joint – 16 (53.3 %), left – 14 (46.7 %). With flexion contracture – 6 cases, mixed – 20, rigidity – 4. In 19 cases (63.3 %) deviation of the lower limb axis was >10°.
We used: X-ray, topogram of lower extremities, CT.
For coagulation status assessment we used: screening coagulation test, levels of scarce coagulation factors (FVIII, FIX), inhibitor of coagulation factor (FVIII, FIX) level.
Function was evaluated before and at 1–9 years postoperatively using KSS, Oxford and VAS scales.
Statistical analysis – STATISTICA 6.0, p < 0.05.
An integrated approach to patients’ management by the use of preoperative planning, surgical techniques, selection of an endoprosthesis of the necessary design and a personalized program of hemostasiological support in the perioperative period that we developed allowed us to obtain excellent results in 1-year period after the operation according to the KSS rating scale in 26 (86.7 %) cases, good in 3 (10 %) cases, satisfactory – in 1 (3.3 %). On the Oxford scale, excellent results were obtained in 25 (83.3 %) cases, good in 4 (13.3 %) cases, satisfactory in 1 (3.3 %). 1–9 years after the operation, no statistically significant differences were obtained in the results with data of 1 year (p > 0.05).
The developed tactics of hemostatic replacement therapy and laboratory control provided satisfactory hemostasis in the perioperative period.
About the Authors
B. V. MaliukBelarus
Bahdan V. Maliuk – Ph. D. (Med.), Senior researcher
60/4, Kizhevatov Str., 220024, Minsk
M. A. Gerasimenko
Belarus
Mihail A. Gerasimenko – D. Sc. (Med.), Professor, Director
60/4, Kizhevatov Str., 220024
O. L. Eismont
Belarus
Oleg L. Eismont – D. Sc. (Med.), Assistant Professor, Deputy Director
60/4, Kizhevatov Str., 220024
V. A. Zmachinsky
Belarus
Vladimir A. Zmachinsky – D. Sc. (Med.), Professor
3/3, P. Brovka Str., 220013
A. B. Dzemiantsou
Belarus
Andrey B. Dzemiantsou – Ph. D. (Med.), Assistant Professor, Leading researcher
60/4, Kizhevatov Str., 220024
References
1. Andreeva T. Hemophilia. Hematology: the newest handbook. Moscow, Saint Petersburg, 2004, рр. 373–389 (in Russian).
2. Chernov V. M., Rumyantsev A. G. Topical problems of hemophilia in research of Russian scientists (analytical review of literature). Voprosy gematologii/onkologii i immunopatologii v pediatrii [Issues of hematology/oncology and immunopathology in pediatrics], 2008, vol. 7, no. 1, рр. 5–16 (in Russian).
3. Hoyer L. W. Hemophilia A. New England Journal of Medicine, 1994, vol. 330, no. 1, pp. 38–47. https://doi.org/10.1056/nejm199401063300108
4. Ironside J. W. Variant Creutzfeldt-Jakob disease: risk of transmission by blood transfusion and blood therapies. Haemophilia, 2006, vol. 12, no. s1, pp. 8–12. https://doi.org/10.1111/j.1365-2516.2006.01195.x
5. Danilov I. P., Zmachinskii V. A., Tsvirko D. G., Potapnev M. P., Dashkevich E. V. Hemophilia. Meditsinskie novosti [Medical news], 2008, no. 13, pp. 20–23 (in Russian).
6. Aledort L. M., Haschmeyer R. H., Pettersson H. A longitudinalstudy of orthopeаdic outcomesforsevere factor-VIII-deficient hemophiliacs. Journal of Internal Medicine, 1994, vol. 236, no. 4, pp. 391–399. https://doi.org/10.1111/j.1365-2796.1994.tb00815.x
7. Kabaeva E. N., Zmachinskii V. A., Khamko K. M., Tsvirko D. G., Maslo V. I. Comparative assessment of the effectiveness of medical rehabilitation of the musculoskeletal system in patients with severe hemophilia. Meditsinskie novosti [Medical news], 2014, no. 4, pp. 59–61 (in Russian).
8. Volkova L. I., Shpilevskii I. E. Rifampicin in the treatment of recurrent hemarthrosis in chronic synovitis. Retsept [Prescription], 2006, vol. 47, no. 3, pp. 115–117 (in Russian).
9. Luck J. V. Jr., Silva M., Rodriguez-Merchan C. E., Ghalambor N., Zahiri C. A., Finn R. S. Hemophilic arthropathy. Journal of the American Academy of Orthopaedic Surgeons, 2004, vol. 12, no. 4, pp. 234–245. https://doi.org/10.5435/00124635- 200407000-00004
10. Chemis A. G., Roshchina L. C., Proskurina N. V. Experimental study of safety of synoviorthesis with rifampicin. Gematologiya i transfuziologiya [Hematology and transfusiology], 2010, vol. 55, no. 2, pp. 30–32 (in Russian).
11. Maliuk B., Eismont O., Biletsky A., Zmachinsky V., Dzemiantsou A. Total knee replacement in patients with hemophilia in a pronounced axial strain and instability. Abstracts of WFH 15th International musculoskeletal congress. Seoul, Republic of Korea, 5–7 May, 2017. Seoul, 2017, p. 34.
12. Andreev Yu. N. Surgical treatment of severe changes of musculoskeletal system in patients with hemophilia. Abstract of Ph. D. diss. Moscow, 1975. 19 p. (in Russian).
13. Kay L., Stainsby D., Burrard B., Fearns M., Hamilton P. J., Owen P., Jones P. The role of synovectomy in the management of recurrent hemarthrosis in hemophilia. British Journal of Haematology, 1981, vol. 49, no. 1, pp. 53–60. https://doi.org/10.1111/j.1365-2141.1981.tb07196.x
14. Barkagan Z. S. Transfusion therapy of hemostasis disorders. Clinical transfusion. Moscow, 1998, pp. 417–444 (in Russian).
15. Barkagan Z. S., Buevich E. I. Modern methods of therapy and rehabilitation of patients with hemophilia with immune inhibitors of anti-hemophilic factors. Gematologiya i transfuziologiya [Hematology and transfusiology], 1996, no. 5, pp. 8–11 (in Russian).
16. Kaufman R. J., Pipe S. W. Regulation of factor VIII expression and activity by von Willebrand factor. Thrombosis and Haemostasis, 1999, vol. 82, no. 08, pp. 201–208. https://doi.org/10.1055/s-0037-1615834
17. Andreev Yu. N. Topical problems of surgical treatment of musculoskeletal system in patients with hemophilia. Gematologiya i transfuziologiya [Hematology and transfusiology], 2001, vol. 46, no. 3, pp. 65–74 (in Russian).
18. Andreev Yu. N. Multiple hemophilia. Moscow, N’yudiamed Publ., 2006. 215 p. (in Russian).
19. Kazemirskii A. V., Novoselov K. A., Kulyaba T. A. Compensation of osteonecrotic defects of condiles in knee endoprosthesis. Endoprotezirovanie v Rossii: vserossiiskii monotematicheskii sbornik nauchnykh statei. Vypusk 2 [Endoprosthetics in Russia: All-Russian monothematic collection of scientific articles. Issue 2]. Kazan, 2006, pp. 197–206 (in Russian).
20. Silva M., Luck J. Long-term results of primary total knee replacement in patients with hemophilia. Journal of Bone and Joint Surgery, 2005, vol. 87, no. 1, pp. 85–91. https://doi.org/10.2106/jbjs.c.01609
21. Protocol of management of patients “Hemophilia”. Problemy standartizatsii v zdravookhranenii [Standardization problems in health care], 2006, no. 3, pp. 18–74 (in Russian).
22. Vorob’ev A. I. (ed.). Guide to hematology. Vol. 3. Moscow, N’yudiamed Publ., 2005. 416 p. (in Russian).
23. Canadian Hemophilia Standards Group. Canadian Comprehensive Care Standards for Hemophilia and Other Inherited Bleeding Disorders, First Edition, June 2007. Available at: https://www.ahcdc.ca/storage/files/comprehensivecarestandards-en.pdf (accessed 23.03.2020).
24. Srivastava A., Brewer A. K., Mauser-Bunschoten E. P., Key N. S., Kitchen S., Llinas A., Ludlam C. A., Mahlangu J. N., Mulder K., Poon M. C., Street A. Guidelines for the management of hemophilia. Hemophilia, 2013, vol. 19, no. 1, pp. 1–47. https://doi.org/10.1111/j.1365-2516.2012.02909.x
25. Laurin C., Dussault R., Levesque H. The tangential X-ray investigation of the patellofemoral joint. Clinical Orthopaedics and Related Research, 1979, no. 144, pp. 16–26. https://doi.org/10.1097/00003086-197910000-00004
26. Merchant A. C. Patellofemoral disorders: biomechanics, diagnosis, and nonoperative treatment. Operative arthroscopy. New York, 1990, pp. 261–275.
27. Merchant A. C., Mercer R. L., Jacobsen R. H., Cool C. R. Roentgenographic analysis of patellofemoral congruence. Journal of Bone and Joint Surgery, 1974, vol. 56, no. 7, pp. 1391–1396. https://doi.org/10.2106/00004623-197456070-00007
28. Kennedy W. F., Bonica J. J., Akamatsu T. J., Ward R. J., Martin W. B., Grinstein A. Cardiovascular and respiratory effects of Subarachnoid block in the presence of acute blood loss. Anesthesiology, 1968, vol. 29, no. 1, pp. 29–35. https://doi.org/10.1097/00000542-196801000-00012
29. Flordal P. A., Neander G. Blood loss in total hip replacement. A retrospective study. Archives of Orthopaedic and Trauma Surgery, 1991, vol. 111, no. 1, pp. 34–38. https://doi.org/10.1007/bf00390191
30. Ezhov I. Yu., Zagrekov V. I., Korytkin A. A., Levin G. Ya., Shebashev A. V., Belousov B. Yu. Objective assessment of intracascular thrombotic complications in hip endoprosthesis. Travmatologiya i ortopediya Rossii [Traumatology and orthopaedics of Russia], 2009, no. 3 (53), pp. 133–135 (in Russian).
31. Korzh A. A., Pashchuk A. Yu., Buklei P. A., Pushkarenko I. G. On autohemotransfusion in orthopaedic practice. Ortopediya, travmatologiya i endoprotezirovanie [Orthopaedia, traumatology and endoprosthesis], 1971, no. 10, pp. 32–34 (in Russian).
32. Kornilov N. V., Karpov V. I., Kustov V. M. Fat embolism as a real danger in endoprosthesis of lower extremity joints. Travmatologiya i ortopediya Rossii [Traumatology and orthopaedics of Russia], 1996, no. 4, pp. 40–42 (in Russian).
33. Peterson M. G. E., Hollenberg J. P., Johanson N. A., Charlson M. E. Geographic varations in rate of THR in the USA. Arthritis & Rheumatology, 1990, p. 59.
34. Tikhilov R. M., Kustov V. M., Kazarin V. S. Reinfusion of drainage blood after endoprosthesis of large joints. Travmatologiya i ortopediya Rossii [Traumatology and orthopaedics of Russia], 2007, no. 2 (44), pp. 5–11.
35. Niskanen R. O., Korkala O. L. Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis. Acta Orthopaedica, 2005, vol. 76, no. 6, pp. 829–832. https://doi.org/10.1080/17453670510045444
36. Knutson J. E., Deering J. A., Hall F. W., Nuttall G. A., Schroeder D. R., White R. D., Mullany C. J. Does intraoperative hetastarch administration increase blood loss and transfusion requirements after cardiac surgery? Anesthesia & Analgesia, 2000, vol. 9, no. 4, pp. 801–807. https://doi.org/10.1097/00000539-200004000-00006
37. Zakarija A., Aledort L. How we treat: venous thromboembolism prevention in hemophilia patients undergoing major orthopaedic surgery. Haemophilia, 2009, vol. 15, no. 6, pp. 1308–1310. https://doi.org/10.1111/j.1365-2516.2009.02060.x
38. Kashyap R., Sharma L., Gupta S., Saxena R., Srivastava D. N. Deep vein thrombosis in a patient with severe hemophilia A. Haemophilia, 2006, vol. 12, no. 1, pp. 87–89. https://doi.org/10.1111/j.1365-2516.2006.01179.x
39. Verhamme P., Tangelder M., Verhaeghe R., Ageno W., Glazer S., Prins M., Jacquemin M., Büller H. Single intravenous administration of TB-402 for the prophylaxis of venous thromboembolism after total knee replacement: a dose-escalating, randomized, controlled trial. Journal of Thrombosis and Haemostasis, 2011, vol. 9, no. 4, pp. 664–671. https://doi.org/10.1111/j.1538-7836.2011.04221.x
40. Paley D. Normal lower limb alignment and joint orientation. Principales of deformity correction. Berlin, 2002, рр. 1–18.
Review
For citations:
Maliuk B.V., Gerasimenko M.A., Eismont O.L., Zmachinsky V.A., Dzemiantsou A.B. Total knee replacement in patients with hemophilia with severe axial deformation and combined instability. Proceedings of the National Academy of Sciences of Belarus, Medical series. 2020;17(2):191-202. (In Russ.) https://doi.org/10.29235/1814-6023-2020-17-2-191-202